Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure and receptor activity for classical cannabinoids.

H H Seltzman1

  • 1Chemistry & Life Sciences, Research Triangle Institute, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709-2194, USA.

Current Medicinal Chemistry
|September 2, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis and physicochemical characterization of (6S)-5-formiminotetrahydrofolate; a reference standard for metabolomics.

Organic & biomolecular chemistry·2018
Same author

The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes.

Journal of medicinal chemistry·1998
Same author

Comparative receptor binding analyses of cannabinoid agonists and antagonists.

The Journal of pharmacology and experimental therapeutics·1998
Same author

Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide.

Journal of medicinal chemistry·1997
Same author

Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs.

Journal of medicinal chemistry·1997
Same author

Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3 beta-(4-[125I]iodophenyl) tropan-2 beta-carboxylic acid isopropyl ester ([125I]RTI-121).

Nuclear medicine and biology·1996

Understanding cannabinoid structure-activity relationships (SAR) now focuses on ligand-receptor interactions. This approach guides the development of novel cannabinoids with targeted pharmacological effects.

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Neuroscience

Background:

  • Classical cannabinoid structure-activity relationship (SAR) studies are increasingly interpreted through the lens of ligand-receptor interactions.
  • Understanding these interactions is crucial for deciphering the neurochemical systems modulated by cannabinoids.

Purpose of the Study:

  • To review the SAR of classical cannabinoids from a receptor interaction perspective.
  • To highlight how receptor-based studies inform the design of novel cannabinoid analogs.

Main Methods:

  • Utilizing in vitro assays, including receptor binding affinity and functional assays (agonist/antagonist), to study cannabinoid pharmacology.
  • Employing transfected receptor systems and distinguishing between receptor subtypes.
  • Integrating computational methods to analyze ligand similarities and receptor structures.

Related Experiment Videos

Main Results:

  • A positive correlation exists between binding affinity and behavioral effects, validating ligand-receptor interaction as a key focus.
  • Computational and experimental data are converging to create a physical model of cannabinoid-receptor interactions.
  • This evolving understanding guides medicinal chemists in designing selective cannabinoid analogs.

Conclusions:

  • A receptor-centric view of cannabinoid SAR is essential for developing compounds with precise pharmacological activities.
  • The integration of experimental and computational approaches provides a sophisticated understanding of cannabinoid pharmacology.
  • This knowledge facilitates the design of new cannabinoids as both therapeutic agents and research tools.